Literature DB >> 21332274

Prevalence of low high-density lipoprotein cholesterol (HDL-C) as a marker of residual cardiovascular risk among acute coronary syndrome patients from Oman.

Ibrahim Al-Zakwani1, Kadhim Sulaiman, Khalid Al-Rasadi, Dimitri P Mikhailidis.   

Abstract

OBJECTIVE: To estimate the prevalence as well as predictors of low high-density lipoprotein cholesterol (HDL-C) levels among acute coronary syndrome (ACS) patients in Oman.
METHODS: Data were analyzed from the records of 1583 consecutive patients admitted with a diagnosis of ACS as part of the Gulf Registry of Acute Coronary Events (Gulf RACE). A low HDL-C was considered as <40 mg/dL for males and <50 mg/dL for females.
RESULTS: The overall mean age of the cohort was 59 ± 13 years ranging from 19 to 102 with patients being mostly male (62%) and Omani (83%). The majority were on statin therapy (84%) and 1.1% were on fenofibrate. The overall prevalence of low HDL-C for this ACS population in Oman was 53% mostly affecting females (67 vs. 43%; p < 0.001). After covariate adjustment, renal impairment (serum creatinine >2 mg/dL), triglycerides, and body mass index (BMI) were positive predictors of low HDL-C. However, male gender, total cholesterol, and heart failure (Killip class score ≥3) were negative predictors of low HDL-C.
CONCLUSIONS: Omani ACS patients have a high prevalence of low HDL-C. Renal impairment, triglycerides, and BMI were positive predictors of low HDL-C. The clinical relevance of a low HDL-C abnormality needs to be evaluated in light of the study's limitations (e.g., cross sectional study design as well as the effects of the acute phase reaction and treatment).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21332274     DOI: 10.1185/03007995.2011.559537

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  5 in total

1.  Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity.

Authors:  Rai Ajit K Srivastava
Journal:  J Diabetes Metab Disord       Date:  2018-11-29

2.  Prevalence, Predictors, and Impact of Low High-Density Lipoprotein Cholesterol on in-Hospital Outcomes Among Acute Coronary Syndrome Patients in the Middle East.

Authors:  Khalid Al-Rasadi; Ibrahim Al-Zakwani; Mohammad Zubaid; Amr Ali; Yasser Bahnacy; Kadhim Sulaiman; Wael Al Mahmeed; Jassim Al Suwaidi; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2011-08-30

3.  Dysfunctional high-density lipoprotein: not only quantity but first of all quality?

Authors:  Aris P Agouridis; Maciej Banach; Dimitri P Mikhailidis
Journal:  Arch Med Sci       Date:  2015-03-14       Impact factor: 3.318

4.  microRNA-3646 serves as a diagnostic marker and mediates the inflammatory response induced by acute coronary syndrome.

Authors:  Jinming Yu; Yongmei Li; Deguo Leng; Cheng Cao; Yongzhi Yu; Yijuan Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Prevalence, Characteristics, and In-Hospital Outcomes of Metabolic Syndrome among Patients with Acute Coronary Syndrome in the United Arab Emirates.

Authors:  Abdulla Shehab; Bayan Al-Dabbagh; Wael Almahmeed; Nazar Bustani; Nicolaas Nagelkerke; Abdulla Alnaeemi; Alawi A Alsheikh-Ali
Journal:  Open Cardiovasc Med J       Date:  2012-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.